Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TFPI | P10646 | 7/20 | 0.54 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.50 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.50 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.50 |
| ▸ | NPY2R | P49146 | 7/20 | 0.50 |
| ▸ | NPY4R | P50391 | 7/20 | 0.50 |
| ▸ | NPY5R | Q15761 | 7/20 | 0.50 |
| ▸ | NPY1R | P25929 | 5/20 | 0.50 |
| ▸ | F2 | P00734 | 2/20 | 0.49 |
| ▸ | IL23R | Q5VWK5 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30531780 | 0.91 | TFPI (0.53) | TFPIOPRM1OPRD1OPRK1NPY2R | |
| SCHEMBL13645144 | 0.84 | NPY2R (0.48) | TFPIOPRM1OPRD1OPRK1NPY2R | |
| SCHEMBL19709273 | 0.78 | KDM1A (0.60) | TFPINPY2RNPY4RNPY5RNPY1R | |
| SCHEMBL31745635 | 0.78 | NPY2R (0.64) | TFPINPY2RNPY4RNPY5RNPY1R | |
| SCHEMBL29352561 | 0.77 | KEAP1 (0.64) | OPRM1OPRD1OPRK1F2 | |
| SCHEMBL19709276 | 0.77 | KDM1A (0.61) | TFPINPY2RNPY4RNPY5RNPY1R | |
| SCHEMBL29405698 | 0.77 | TFPI (0.70) | TFPINPY2RNPY4RNPY5RNPY1R | |
| SCHEMBL30607403 | 0.76 | CALCR (0.67) | TFPIOPRM1OPRD1OPRK1NPY2R | |
| SCHEMBL31182783 | 0.76 | CALCR (0.63) | TFPINPY2RNPY4RNPY5RNPY1R | |
| SCHEMBL31688332 | 0.76 | OPRM1 (0.61) | OPRM1OPRD1OPRK1F2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100040542-A1 | CHELATOR CONJUGATES | GE HEALTHCARE LIMITED (GB) | 2010-02-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100040542-A1 | CHELATOR CONJUGATES | SLC40A1, TFRC, SLC39A3 | TFPI 3708/4885OPRM1 4072/4885OPRD1 4583/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.